Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BAVARIAN NORDIC

🇩🇰Denmark

Country: 🇩🇰Denmark

Ownership: -

Established: 1992-01-01

Employees: 759

Market Cap: $3.1B

Website: http://www.bavarian-nordic.com

Clinical Trials

Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury)

Phase 1

Completed

Conditions: Safety Issues

Interventions: Biological: MVA-BN-Brachyury/ FPV-Brachyury

First Posted Date: 2017-11-22

Last Posted Date: 2020-08-26

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 11

Registration Number: NCT03349983

Locations: 🇺🇸
Genitourinary Malignancies Branch National Cancer Institute, Bethesda, Maryland, United States

VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

Phase 4

Completed

Conditions: Cholera (Disorder)

Interventions: Biological: VAXCHORA (Cholera Vaccine, Live, Oral)
Other: Placebo

First Posted Date: 2017-07-18

Last Posted Date: 2023-06-28

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 550

Registration Number: NCT03220737

Locations: 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Johnson County Clin-Trials, Inc., Lenexa, Kansas, United States
🇺🇸
Heartland Research Associates, LLC, Wichita, Kansas, United States

and more 7 locations

RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults

Phase 2

Completed

Conditions: Respiratory Syncytial Virus Infections

Interventions: Biological: MVA-BN-RSV
Other: Placebo

First Posted Date: 2016-08-19

Last Posted Date: 2020-09-22

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 420

Registration Number: NCT02873286

Locations: 🇺🇸
Paradigm Research, Redding, California, United States
🇺🇸
Optimal Research, Rockville, Maryland, United States
🇺🇸
Compass Research, The Villages, Florida, United States

and more 7 locations

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

Phase 1

Withdrawn

Conditions: Respiratory Syncytial Virus Infections

Interventions: Biological: MVA-BN-RSV
Other: Placebo

First Posted Date: 2016-08-12

Last Posted Date: 2018-08-27

Lead Sponsor: Bavarian Nordic

Registration Number: NCT02864628

A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Non-small Cell Lung Cancer (NSCLC)

Interventions: Biological: CV301
Biological: Pembrolizumab
Biological: Nivolumab

First Posted Date: 2016-07-21

Last Posted Date: 2020-02-27

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 24

Registration Number: NCT02840994

Locations: 🇺🇸
H. Lee Moffitt Cancer Center & Research Institute, Inc., Tampa, Florida, United States
🇺🇸
Investigative Clinical Research of Indiana, Indianapolis, Indiana, United States
🇺🇸
Metairie Oncologist, LLC, Metairie, Louisiana, United States

and more 4 locations

Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine

Phase 1

Completed

Conditions: Respiratory Syncytial Virus Infections

Interventions: Biological: MVA BN RSV
Other: Placebo

First Posted Date: 2015-04-17

Last Posted Date: 2016-08-10

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 63

Registration Number: NCT02419391

Locations: 🇺🇸
Johnson County Clin-Trials (JCCT), Lenexa, Kansas, United States

Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers

Completed

Conditions: Typhoid Fever

Interventions: Biological: Vivotif

First Posted Date: 2015-03-18

Last Posted Date: 2023-07-07

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 855

Registration Number: NCT02391909

Locations: 🇺🇸
Passport Health, Baltimore, Maryland, United States

A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults

Phase 3

Completed

Conditions: Cholera

Interventions: Biological: PXVX0200
Biological: Placebo

First Posted Date: 2014-04-01

Last Posted Date: 2023-06-28

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 398

Registration Number: NCT02100631

Locations: 🇺🇸
Coastal Clinical Research, Mobile, Alabama, United States
🇺🇸
Avail Clinical, DeLand, Florida, United States
🇺🇸
Miami Research Associates, Miami, Florida, United States

and more 13 locations

A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults

Phase 3

Completed

Conditions: Cholera

Interventions: Biological: PXVX0200 Lot B
Biological: Placebo
Biological: PXVX0200 Lot A
Biological: PXVX0200 Lot C

First Posted Date: 2014-03-24

Last Posted Date: 2023-06-28

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 3146

Registration Number: NCT02094586

Locations: 🇺🇸
Coastal Clinical Research, Mobile, Alabama, United States
🇺🇸
Clinical Reseach Consortium Arizona, Phoenix, Arizona, United States
🇺🇸
Avail Clinical Research, DeLand, Florida, United States

and more 22 locations

Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection

Phase 2

Completed

Conditions: Smallpox

Interventions: Biological: IMVAMUNE®

First Posted Date: 2014-01-17

Last Posted Date: 2020-04-02

Lead Sponsor: Bavarian Nordic

Target Recruit Count: 87

Registration Number: NCT02038881

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Health for Life Clinic Little Rock, Little Rock, Arkansas, United States
🇺🇸
Quest Clinical Research, San Francisco, California, United States

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy